News
In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...
Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid's EsoGuard Esophageal DNA Test, as an acceptable alternative to endoscopy "This update is an important ...
About Lucid DiagnosticsLucid Diagnostics Inc. is a commercial-stage, cancer prevention ... national-comprehensive-cancer-network-nccn-guidelines-now-include-esophageal-precancer-screening ...
Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid's EsoGuard Esophageal DNA Test, as an acceptable alternative to endoscopy Lucid Diagnostics Inc., markets the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results